Carregant...
Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009
BACKGROUND: New emerging infections have no known treatment. Assessing potential drugs for safety and efficacy enables clinicians to make evidence-based treatment decisions and contributes to overall outbreak control. However, it is difficult to launch clinical trials in the unpredictable environmen...
Guardat en:
| Publicat a: | BMC Med |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7441224/ https://ncbi.nlm.nih.gov/pubmed/32825816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-020-01732-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|